Innovate. Accelerate. Change Lives.
Conduit Pharmaceuticals Limited (“Conduit”) is led by highly experienced pharma executives, Dr. Freda Lewis-Hall and Dr. David Tapolczay, to fund the development of successful deprioritized clinical assets licensed from large pharmaceutical companies.
